Coherus Oncology (CHRS) Gross Margin Growth (1y) (2020 - 2026)
Coherus Oncology (CHRS) Gross Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
526.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-5.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
393.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
393.00 |
| Dec 31, 2025 |
383.00 |
| Sep 30, 2025 |
1,293.00 |
| Jun 30, 2025 |
-1,554.00 |
| Mar 31, 2025 |
2,744.00 |
| Dec 31, 2024 |
5,684.00 |
| Sep 30, 2024 |
-124.00 |
| Jun 30, 2024 |
2,475.00 |
| Mar 31, 2024 |
-1,033.00 |
| Dec 31, 2023 |
-6,108.00 |
| Sep 30, 2023 |
3,371.00 |
| Jun 30, 2023 |
-2,357.00 |
| Mar 31, 2023 |
-3,644.00 |
| Dec 31, 2022 |
-1,482.00 |
| Sep 30, 2022 |
-5,177.00 |
| Jun 30, 2022 |
31.00 |
| Mar 31, 2022 |
-654.00 |
| Dec 31, 2021 |
-593.00 |
| Sep 30, 2021 |
-1,787.00 |
| Jun 30, 2021 |
-1,159.00 |
